NDSI
HSTO

Newman Dignan & Sheerar Inc’s Histogen Inc. Common Stock HSTO Stock Holding History

Newman Dignan & Sheerar Inc’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,626
Closed -$13 – 212
2022
Q1 		$13 Hold
2,626
– – ﹤0.01% 196
2021
Q4 		$17K Hold
2,626
– – 0.01% 203
2021
Q3 		$40K Buy
+2,626
New +$44.4K 0.01% 188
2021
Q2 		– Sell
-1,626
Closed -$42K – 193
2021
Q1 		$42K Buy
+1,626
New +$40.8K 0.02% 179

Other funds holding HSTO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Newman Dignan & Sheerar Inc's HSTO Position: Q2 2022 in Review

Newman Dignan & Sheerar Inc sold out of Histogen Inc. Common Stock (HSTO) in Q2 2022, closing a stake of 2,626 shares — an estimated $13 sold.

Newman Dignan & Sheerar Inc first reported a position in HSTO in Q1 2021 and held it in 4 quarters. The position peaked at $42K in Q1 2021. 10 funds tracked by Wall St. Rank hold HSTO as of Q2 2022.

  • Newman Dignan & Sheerar Inc reported no remaining Histogen Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Newman Dignan & Sheerar Inc sold 2,626 Histogen Inc. Common Stock shares in Q2 2022, an estimated $13.
  • Newman Dignan & Sheerar Inc first reported a position in Histogen Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • Newman Dignan & Sheerar Inc's Histogen Inc. Common Stock position peaked at $42K in Q1 2021.
  • 10 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2022.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2022, filed 3 Aug 2022.